Samuel Bernal

In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against aspergillus spp

María del Carmen Serrano, Anastasio Valverde-Conde, M.ónica Chávez et al. · Diagnostic Microbiology and Infectious Disease · 2003 · 77 citations

Life Sciences, Microbiology, Pharmacology +16

New findings in HCV genotype distribution in selected West European, Russian and Israeli regions

Vladimir Kartashev, Matthias Döring, Leonardo Nieto et al. · Journal of Clinical Virology · 2016 · 73 citations · Full text

Life Sciences, Genetics, Infectious Diseases +17

Evaluation of CHROMagar candida medium for the isolation and presumptive identification of species of candida of clinical importance

Samuel Bernal, Estrella Martín‐Mazuelos, Martha Martínez-Garcia et al. · Diagnostic Microbiology and Infectious Disease · 1996 · 67 citations

Life Sciences, Infectious Diseases, Microbiology +13

Significant ecological impact on the progression of fluoroquinolone resistance in Escherichia coli with increased community use of moxifloxacin, levofloxacin and amoxicillin/clavulanic acid

Óscar Cuevas, Jesús Oteo, Ester Lázaro et al. · Journal of Antimicrobial Chemotherapy · 2010 · 56 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

In-vitro activity of voriconazole (UK-109,496), LY303366 and other antifungal agents against oral Candida spp. isolates from HIV-infected patients

Mónica Chávez, Samuel Bernal, Anastasio Valverde et al. · Journal of Antimicrobial Chemotherapy · 1999 · 55 citations · Full text

Pharmacy, Microbiology, Pharmacotherapy +17